Breaking News Instant updates and real-time market news.

NUVA

NuVasive

$49.55

-0.96 (-1.90%)

16:32
02/08/19
02/08
16:32
02/08/19
16:32

NuVasive up 25% to $62.00 after FT reports possible buyout by Smith & Nephew

  • 06

    Mar

NUVA NuVasive
$49.55

-0.96 (-1.90%)

01/07/19
PIPR
01/07/19
NO CHANGE
Target $70
PIPR
Overweight
NuVasive shares 'cheap' with 2019 looking brighter than Q4, says Piper Jaffray
Piper Jaffray analyst Matt O'Brien said he understand concerns about NuVasive's $6M Q4 revenue miss versus consensus, but he believes based on his view of the company's "innovative products" and year-end checks indicating that the spine market is improving that the company should see "a beat-and-raise dynamic" next year. NuVasive is "still a great earnings power story" and the shares looks "very cheap" on an EV/EBITDA basis, said O'Brien, who keeps an Overweight rating on the stock with a price target of $70.
01/17/19
BTIG
01/17/19
NO CHANGE
Target $59
BTIG
Buy
NuVasive price target lowered to $59 from $70 at BTIG
BTIG analyst Ryan Zimmerman lowered his price target on NuVasive to $59 after meeting with its CEO Chris Barry, saying that he was "upfront" about the company FY18 results and may take the opportunity to reset expectations entering FY19. The analyst also keeps his Buy rating on NuVasive shares, noting that its valuation is at a 3-year lows even though the company is looking to accelerate its potential robotic commercialization.
02/08/19
NEED
02/08/19
DOWNGRADE
NEED
Hold
NuVasive downgraded to Hold from Buy at Needham
02/08/19
NEED
02/08/19
DOWNGRADE
NEED
Hold
NuVasive downgraded to Hold from Buy at Needham
Needham analyst Mike Matson downgraded NuVasive to Hold to reflect the potential headwinds that the stock may experience from the company's expected revenue miss, reinvestment weight on margins, and the overall potential of slowing revenue growth. The analyst adds that NuVasive comps are set to become progressively more difficult starting in Q1 of FY19 and also warns that the company may "lose share to competitors with robots until it launches its own robot." Matson also lowers his FY19 EPS view to $2.46 from $2.52 and revenue to $1.15B from $1.17B.

TODAY'S FREE FLY STORIES

QCOM

Qualcomm

$75.75

0.09 (0.12%)

05:42
07/18/19
07/18
05:42
07/18/19
05:42
Downgrade
Qualcomm rating change  »

Barclays downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

SBNY

Signature Bank

$124.89

-0.41 (-0.33%)

05:42
07/18/19
07/18
05:42
07/18/19
05:42
Earnings
Signature Bank reports Q2 EPS $2.72, consensus $2.71 »

Reports Q2 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

AGN

Allergan

$162.57

-1.69 (-1.03%)

, ABBV

AbbVie

$68.32

-0.82 (-1.19%)

05:39
07/18/19
07/18
05:39
07/18/19
05:39
Downgrade
Allergan, AbbVie rating change  »

Allergan downgraded to…

AGN

Allergan

$162.57

-1.69 (-1.03%)

ABBV

AbbVie

$68.32

-0.82 (-1.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 09

    Sep

  • 16

    Sep

  • 02

    Oct

SAP

SAP

$134.22

-0.9 (-0.67%)

05:39
07/18/19
07/18
05:39
07/18/19
05:39
Earnings
SAP expects FY19 revenue to 'increase strongly' »

Backs FY19 cloud revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 01

    Aug

SAP

SAP

$134.22

-0.9 (-0.67%)

05:33
07/18/19
07/18
05:33
07/18/19
05:33
Earnings
SAP reports Q2 non-IFRS EPS EUR 1.09 vs. EUR 0.98 last year »

Reports Q2 revenue EUR…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 01

    Aug

CMA

Comerica

$69.23

-2.52 (-3.51%)

05:26
07/18/19
07/18
05:26
07/18/19
05:26
Downgrade
Comerica rating change  »

Comerica downgraded to In…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

EBAY

eBay

$39.03

-0.87 (-2.18%)

05:26
07/18/19
07/18
05:26
07/18/19
05:26
Recommendations
eBay analyst commentary  »

eBay price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$362.50

-3.22 (-0.88%)

05:23
07/18/19
07/18
05:23
07/18/19
05:23
Recommendations
Netflix analyst commentary  »

Netflix content lineup…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASML

ASML

$217.73

12.67 (6.18%)

05:20
07/18/19
07/18
05:20
07/18/19
05:20
Downgrade
ASML rating change  »

ASML downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$90.11

0.99 (1.11%)

05:20
07/18/19
07/18
05:20
07/18/19
05:20
Earnings
Novartis raises FY19 revenue view to up mid to high-single digit »

Novartis provided the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 22

    Jul

  • 23

    Jul

  • 25

    Sep

SWKS

Skyworks

$80.15

-1.14 (-1.40%)

05:18
07/18/19
07/18
05:18
07/18/19
05:18
Upgrade
Skyworks rating change  »

Skyworks upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$203.32

-1.08 (-0.53%)

05:18
07/18/19
07/18
05:18
07/18/19
05:18
Upgrade
Apple rating change  »

Apple upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

SWKS

Skyworks

$80.15

-1.14 (-1.40%)

05:16
07/18/19
07/18
05:16
07/18/19
05:16
Downgrade
Skyworks rating change  »

Skyworks downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QCOM

Qualcomm

$75.75

0.09 (0.12%)

05:15
07/18/19
07/18
05:15
07/18/19
05:15
Downgrade
Qualcomm rating change  »

Qualcomm downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

VET

Vermilion Energy

$21.12

-0.44 (-2.04%)

05:14
07/18/19
07/18
05:14
07/18/19
05:14
Downgrade
Vermilion Energy rating change  »

Vermilion Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jul

XOM

Exxon Mobil

$75.49

-0.44 (-0.58%)

05:13
07/18/19
07/18
05:13
07/18/19
05:13
Downgrade
Exxon Mobil rating change  »

Exxon Mobil downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

TTD

Trade Desk

$244.23

0.72 (0.30%)

05:12
07/18/19
07/18
05:12
07/18/19
05:12
Downgrade
Trade Desk rating change  »

Trade Desk downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$90.11

0.99 (1.11%)

05:11
07/18/19
07/18
05:11
07/18/19
05:11
Earnings
Novartis reports Q2 core EPS $1.34, consensus $1.22 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 22

    Jul

  • 23

    Jul

  • 25

    Sep

IHG

InterContinental

$69.80

-0.16 (-0.23%)

05:11
07/18/19
07/18
05:11
07/18/19
05:11
Downgrade
InterContinental rating change  »

InterContinental…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

WTBDY

Whitbread

$0.00

(0.00%)

05:10
07/18/19
07/18
05:10
07/18/19
05:10
Downgrade
Whitbread rating change  »

Whitbread downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGM

MGM Resorts

$28.85

-0.555 (-1.89%)

05:08
07/18/19
07/18
05:08
07/18/19
05:08
Downgrade
MGM Resorts rating change  »

MGM Resorts downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

EXP

Eagle Materials

$86.46

-0.245 (-0.28%)

05:06
07/18/19
07/18
05:06
07/18/19
05:06
Downgrade
Eagle Materials rating change  »

Eagle Materials…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 06

    Aug

  • 21

    Aug

  • 04

    Sep

  • 13

    Nov

ATI

Allegheny Technologies

$24.47

-0.415 (-1.67%)

05:05
07/18/19
07/18
05:05
07/18/19
05:05
Downgrade
Allegheny Technologies rating change  »

Allegheny Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 06

    Aug

ARNC

Arconic

$25.29

-0.49 (-1.90%)

05:05
07/18/19
07/18
05:05
07/18/19
05:05
Downgrade
Arconic rating change  »

Arconic downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USCR

U.S. Concrete

$50.87

-0.96 (-1.85%)

05:04
07/18/19
07/18
05:04
07/18/19
05:04
Downgrade
U.S. Concrete rating change  »

U.S. Concrete downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 13

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.